Shares of Centene (NYSE:CNC) lost ~10% in the early premarket trading on Friday after the Medicaid-driven managed care firm ...

Analysts have given Centene a total of 16 ratings, with the consensus rating being Neutral. The average one-year price target is $49.62, indicating a potential 68.66% upside.

Centene Corp (CNC) reports a mixed quarter with revenue growth but faces earnings pressure, while outlining strategic plans for margin recovery and future profitability.

The California-based insurer outlined its plans to survive what CEO Joe Zubretsky deemed a “season of great uncertainty” ...

Centene reported a $253 million loss in its second quarter as the provider of government-subsidized health benefits struggles ...

Centene Corporation ( NYSE: CNC) Q2 2025 Earnings Conference Call July 25, 2025 8:30 AM ET a - Corporate Participant v - Corporate Participant Andrew Lynn Asher - Chief Financial Officer Jennifer ...

Analysts are estimating that Molina Healthcare will report an earnings per share (EPS) of $5.92. Investors in Molina ...

Centene stock tumbled after reporting a surprise Q2 loss, driven by rising medical costs and a weak outlook, shaking ...

Centene is responding by repricing plans for 2026 and focusing on cost controls while Medicare Advantage and Prescription ...

HCA Healthcare and Tenet Healthcare, for-profit chains that collectively own 240 hospitals, both said their revenue and ...

Centene’s stock pulled a sharp U-turn into the green, after the health insurer helped assuage investor worries by providing ...

Elevance Health's medical loss ratio was 88.9% in the second quarter, up from 86.4% in the first quarter, reflecting expected ...